Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme

Zhou,Bin; Tang,Zhuo; Deng,Yanchun; Hou,Shuangxing; Liu,Nan; Lin,Wei; Liu,Xinping; Yao,Libo

doi:10.3892/mmr.2014.2237

August-2014 Volume 10 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2014 Volume 10 Issue 2

Full Size Image

Article

Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme

Authors:
- Bin Zhou
- Zhuo Tang
- Yanchun Deng
- Shuangxing Hou
- Nan Liu
- Wei Lin
- Xinping Liu
- Libo Yao
View Affiliations / Copyright

Affiliations: Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Neurosurgery, Xijing Hospital Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
Pages: 891-896
|
Published online on: May 14, 2014

https://doi.org/10.3892/mmr.2014.2237
Expand metrics +

Abstract

N‑myc downstream regulated gene 2 (NDRG2) is highly expressed in numerous normal tissues, while it is marginally expressed or undetectable in various tumors, including lung and colon cancer. In order to investigate the expression of NDRG2 in human glioma and its downstream regulatory mechanisms, quantitative polymerase chain reaction (qPCR), immunohistochemistry and western blot analyses were used to assess NDRG2 mRNA and protein expression in different grades of human glioma and adjacent normal tissues. The methylation status of the NDRG2 promoter region was also determined using bisulfite sequencing. NDRG2 mRNA expression was observed to be significantly lower in glioma tissues than in adjacent normal tissues (P<0.05). Furthermore, a significant negative correlation was found between the glioma tumor grade and NDRG2 expression (P<0.05), at the mRNA and protein levels. Moreover, the methylation rate of the NDRG2 promoter region was 46.3% in the glioma tissues compared with 18.2% in the adjacent normal tissues (P<0.05). These findings show that NDRG2 expression is downregulated in human glioma and that the level of NDRG2 expression negatively correlates with the glioma grade. Furthermore, these findings indicate that NDRG2 downregulation may be due to aberrant methylation of the NDRG2 promoter region and subsequent transcriptional inactivation.

View Figures

View References

1	Qu X, Zhai Y, Wei H, et al: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem. 229:35–44. 2002. View Article : Google Scholar : PubMed/NCBI
2	Chun DY, Bo YL, Ping LX, et al: Exploring a new gene containing ACP like domain in human brain and expression it in E. coli. Prog Biochem Biophys. 28:72–76. 2001.(In Chinese).
3	Lusis EA, Watson MA, Chicoine MR, et al: Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 65:7121–7126. 2005. View Article : Google Scholar
4	Jian L, Ping LX, Xin LS, et al: Expression pattern of ndr2 gene, a candidate tumor-suppressor, in different human tissues and tumors. Prog Biochem Biophys. 29:223–227. 2002.(In Chinese).
5	Ellen TP, Ke Q, Zhang P and Costa M: NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis. 29:2–8. 2008. View Article : Google Scholar : PubMed/NCBI
6	Choi SC, Yoon SR, Park YP, et al: Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med. 39:705–714. 2007. View Article : Google Scholar : PubMed/NCBI
7	Cavenee W, Furnari F, Nagane M, et al: Diffusely infiltrating astrocytomas. Pathology and Genetics of Tumours of the Nervous System. Kleihues P and Cavenee WK: International Agency for Research on Cancer; Lyon, France: pp. 10–21. 2000
8	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
9	Tamai K, Shiina M, Tanaka N, et al: Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. Virology. 422:377–385. 2012. View Article : Google Scholar : PubMed/NCBI
10	Franz M, Grün K, Richter P, et al: Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A⁺ fibronectin, alpha-smooth muscle actin and B⁺ tenascin-C in chronic cardiac allograft rejection. Histochem Cell Biol. 134:503–517. 2010. View Article : Google Scholar : PubMed/NCBI
11	Li W, Chu D, Chu X, et al: Decreased expression of NDRG2 is related to poor overall survival in patients with glioma. J Clin Neurosci. 18:1534–1537. 2011. View Article : Google Scholar : PubMed/NCBI
12	Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
13	Lee DC, Kang YK, Kim WH, et al: Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 68:4210–4220. 2008. View Article : Google Scholar : PubMed/NCBI
14	Melotte V, Qu X, Ongenaert M, et al: The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J. 24:4153–4166. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kim YJ, Yoon SY, Kim JT, et al: NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis. 30:598–605. 2009. View Article : Google Scholar : PubMed/NCBI
16	Hu XL, Liu XP, Lin SX, et al: NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol. 10:3518–3521. 2004.PubMed/NCBI
17	Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61:2847–2851. 2001.PubMed/NCBI
18	Szyf M, Pakneshan P and Rabbani SA: DNA methylation and breast cancer. Biochem Pharmacol. 68:1187–1197. 2004. View Article : Google Scholar : PubMed/NCBI
19	Toyota M, Suzuki H, Sasaki Y, et al: Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles